Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Vertex and Witkowski Partnership

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Feb 19, 2022 6:12pm

126 Views

Post# 34445477

RE:RE:RE:Vertex and Witkowski Partnership

They have some major hurdles to overcome if they plan to go with the Portal vein route.

When injecting straight into frontline immune tissue, immune protection will be more challenging. Another problem is containing and removing any potentially tumorigenic cells. Tumorigenicity is a clinical hurdle for pluripotent stem cells and being able to contain them and remove them is a necessity.

Perhaps Vertex is proving the clinical safety and efficacy of the cells before entering a some kind of collaboration/deal with Sernova. Something doesn't add up IMO.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages